Atossa Therapeutics, Inc. (ATOS)
NASDAQ·Healthcare·Biotechnology
$2.46
-4.86%
Mkt Cap $39.35M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+306.6%
Consensus $10.00 vs current $2.46
NASDAQ·Healthcare·Biotechnology
$2.46
-4.86%
Mkt Cap $39.35M
No recent rating data.
Price Target (2 analysts)
$10.00
Range $10.00 – $10.00
+306.6%
Consensus $10.00 vs current $2.46